Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries

被引:1
|
作者
Sun, CW
Falck, JR
Okamoto, H
Harder, DR
Roman, RJ
机构
[1] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA
[3] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA
关键词
vascular smooth muscle; cytochrome P-450; potassium ion channels; cerebral circulation; 20-hydroxyeicosatetraenoic acid;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examined the response to nitric oxide (NO) in rat middle cerebral arteries (MCA). NO donors increased the activity of a 205-pS K+ channel recorded from vascular smooth muscle (VSM) cells isolated from MCA 10-fold. Blockade of guanylyl cyclase activity with 1H-[1,2,4] oxadiazole[4,3-a] quinoxalin-1-one (ODQ, 10(-5) M) did not alter the effect of NO on this channel. In contrast, adding 20-hydroxyeicosatetraenoic acid (20-HETE) to the bath (10(-7) M) abolished the response to NO. NO donors also increased the diameter of serotonin-preconstricted MCA to 85% of control. Blockade of K+ channels with iberiotoxin or a high-K+ medium reduced this response by 50%. ODQ (10(-5) M) reduced this response by 47 +/- 3%, whereas preventing the fall of 20-HETE levels reduced the response by 59 +/- 2% (n = 5). Blockade of both pathways eliminated the response to NO donors. These results indicate that activation of K+ channels contributes 50% to vasodilator response to NO in rat MCA. This is mediated by a fall in 20-HETE levels rather than a rise in cGMP levels or a direct effect of NO.
引用
收藏
页码:H339 / H350
页数:12
相关论文
共 50 条
  • [31] The cerebrovascular response to elevated potassium - role of nitric oxide in the in vitro model of isolated rat middle cerebral arteries
    Schuh-Hofer, S
    Lobsien, E
    Brodowsky, R
    Vogt, J
    Dreier, JP
    Klee, R
    Dirnagl, U
    Lindauer, U
    NEUROSCIENCE LETTERS, 2001, 306 (1-2) : 61 - 64
  • [32] Interaction between nitric oxide, endothelin-1 and 20-HETE in the differential regulation of renal regional blood flow in the rat.
    Hercule, H
    McGiff, JC
    Oyekan, AO
    FASEB JOURNAL, 1999, 13 (04): : A388 - A388
  • [33] The response of cerebral resistance arteries to step changes in pressure: A role for nitric oxide.
    Doughty, JM
    Langton, PD
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : TH219 - TH219
  • [34] Comparative aspects on nitric oxide in brain and its role as a cerebral vasodilator
    Nilsson, GE
    Söderström, V
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 1997, 118 (04): : 949 - 958
  • [35] Pressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood flow
    Harder, David R.
    Narayanan, Jayashree
    Gebremedhin, Debehe
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2011, 300 (05): : H1557 - H1565
  • [36] Activation of single-channel chloride current by 20-HETE in rat middle cerebral arterial muscle cells
    Gebremedhin, D
    Yamaura, K
    Harder, DR
    FASEB JOURNAL, 2003, 17 (04): : A63 - A63
  • [37] 20-HETE modulates myogenic response of skeletal muscle resistance arteries from hypertensive Dahl-SS rats
    Frisbee, JC
    Roman, RJ
    Krishna, UM
    Falck, JR
    Lombard, JH
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (03): : H1066 - H1074
  • [38] Nitric oxide mediates the pulmonary vasodilator response to nociceptin in the intact rat
    Lin, B
    Patton, S
    Kirschbaum, KS
    Witriol, N
    Franklin, MZ
    Ji, F
    Lippton, H
    FASEB JOURNAL, 2002, 16 (04): : A73 - A73
  • [39] Role of endothelial nitric oxide in the response to angiotensin II of small mesenteric arteries of the rat
    Andriantsitohaina, R
    Okruhlicova, L
    Cortes, SF
    Lagaud, GJL
    Randriamboavonjy, V
    Muller, B
    Stoclet, JC
    JOURNAL OF VASCULAR RESEARCH, 1996, 33 (05) : 386 - 394
  • [40] THE VASODILATOR ROLE OF ENDOGENOUS NITRIC-OXIDE IN THE RAT GASTRIC MICROCIRCULATION
    PIQUE, JM
    WHITTLE, BJR
    ESPLUGUES, JV
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 174 (2-3) : 293 - 296